101 related articles for article (PubMed ID: 15037658)
1. A simple epigenetic method for the diagnosis and classification of brain tumors.
Zukiel R; Nowak S; Barciszewska AM; Gawronska I; Keith G; Barciszewska MZ
Mol Cancer Res; 2004 Mar; 2(3):196-202. PubMed ID: 15037658
[TBL] [Abstract][Full Text] [Related]
2. Analysis of 5-methylcytosine in DNA of breast and colon cancer tissues.
Barciszewska AM; Murawa D; Gawronska I; Murawa P; Nowak S; Barciszewska MZ
IUBMB Life; 2007 Dec; 59(12):765-70. PubMed ID: 18085476
[TBL] [Abstract][Full Text] [Related]
3. TLC-based detection of methylated cytosine: application to aging epigenetics.
Barciszewska MZ; Barciszewska AM; Rattan SI
Biogerontology; 2007 Dec; 8(6):673-8. PubMed ID: 17891469
[TBL] [Abstract][Full Text] [Related]
4. The diagnosis and therapy of brain tumours.
Nowak S; Zukiel R; Barciszewska AM; Barciszewski J
Folia Neuropathol; 2005; 43(3):193-6. PubMed ID: 16245217
[TBL] [Abstract][Full Text] [Related]
5. p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas.
Wakabayashi T; Natsume A; Hatano H; Fujii M; Shimato S; Ito M; Ohno M; Ito S; Ogura M; Yoshida J
Neurosurgery; 2009 Mar; 64(3):455-61; discussion 461-2. PubMed ID: 19240607
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas.
Lavon I; Zrihan D; Zelikovitch B; Fellig Y; Fuchs D; Soffer D; Siegal T
Clin Cancer Res; 2007 Mar; 13(5):1429-37. PubMed ID: 17332285
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
8. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
9. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
[TBL] [Abstract][Full Text] [Related]
10. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
[TBL] [Abstract][Full Text] [Related]
11. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
12. Multigene methylation analysis for detection and staging of prostate cancer.
Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
[TBL] [Abstract][Full Text] [Related]
13. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors.
Fraga MF; Herranz M; Espada J; Ballestar E; Paz MF; Ropero S; Erkek E; Bozdogan O; Peinado H; Niveleau A; Mao JH; Balmain A; Cano A; Esteller M
Cancer Res; 2004 Aug; 64(16):5527-34. PubMed ID: 15313885
[TBL] [Abstract][Full Text] [Related]
14. [Biochemical exploration of energetic metabolism and oxidative stress in low grade gliomas: central and peripheral tumor tissue analysis].
Lamari F; La Schiazza R; Guillevin R; Hainque B; Foglietti MJ; Beaudeux JL; Bernard M
Ann Biol Clin (Paris); 2008; 66(2):143-50. PubMed ID: 18390424
[TBL] [Abstract][Full Text] [Related]
15. Global DNA hypomethylation, rather than reactive oxygen species (ROS), a potential facilitator of cadmium-stimulated K562 cell proliferation.
Huang D; Zhang Y; Qi Y; Chen C; Ji W
Toxicol Lett; 2008 Jun; 179(1):43-7. PubMed ID: 18482805
[TBL] [Abstract][Full Text] [Related]
16. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
[TBL] [Abstract][Full Text] [Related]
18. Total DNA Methylation Changes Reflect Random Oxidative DNA Damage in Gliomas.
Barciszewska AM; Giel-Pietraszuk M; Perrigue PM; Naskręt-Barciszewska M
Cells; 2019 Sep; 8(9):. PubMed ID: 31514401
[TBL] [Abstract][Full Text] [Related]
19. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
20. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.
Hoque MO; Feng Q; Toure P; Dem A; Critchlow CW; Hawes SE; Wood T; Jeronimo C; Rosenbaum E; Stern J; Yu M; Trink B; Kiviat NB; Sidransky D
J Clin Oncol; 2006 Sep; 24(26):4262-9. PubMed ID: 16908936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
